← Back to front page
United States · Markets & Finance · Morningstar

Transcenta Therapeutics Announces Appointment of Ms. Jennie Ma as Chief Financial Officer

Published by Morningstar · United States 8 h ago

Transcenta Therapeutics (HKEX: 06628) today announced that its Board of Directors has approved the appointment of Ms. Jennie Ma as Chief Financial Officer (CFO) of the Company. In…

Read the full article on Morningstar Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.morningstar.com)

Also worth reading